Barrow Neurological Institute at CTAD 2026

Nov 16–19, 2026 Boston, MA ~1.7k attendees Website

Barrow Neurological Institute takes part in 2 sessions at CTAD 2026 in Boston. Its program spans the LEADER real-world study of lecanemab three years after approval and genotype analyses of blarcamesine in early Alzheimer's disease.

OrganizationCTAD 2026 Attendance
barrowneuro.org
Hospitals & health systems
Neurology and neurosurgery centre at St. Joseph's Hospital and Medical Center in Phoenix, with a memory-disorders clinical research program.
Poster
Mon Nov 16 – Tue Nov 17
2:00pm Mon – 5:30pm Tue
Session
Wed Nov 18
11:00am–11:40am

Explore the full CTAD 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Boston. Leave your work email and we’ll be in touch.

Privacy

Download the full CTAD 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from Barrow Neurological Institute

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by the CTAD Conference. Organization details are derived from CTAD’s published program, poster list and sponsor page. Submit a correction